Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9-year, 337-patient, multi-institutional experience

Annals of Oncology

Volumn 15, Issue 8, 2004, Pages 1179-1186

  Brockstein, B ^a,b   Haraf, D J ^c   Rademaker, A W ^b   Kies, M S ^d   Stenson, K M ^c   Rosen, F ^e   Mittal, B B ^b   Pelzer, H ^b   Fung, B B ^b   Witt, M E ^c   Wenig, B ^a,b   Portugal, L ^f   Weichselbaum, R W ^c   Vokes, E E ^c  

^a Evanston Northwestern Healthcare ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Jr Hospital of Cook County   (United States)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Chemoradiotherapy; Head and neck cancer; Induction chemotherapy; Patterns of failure; Prognostic factors

Indexed keywords

ALPHA INTERFERON; CISPLATIN; FLUOROURACIL; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXPERIENCE; FEMALE; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; META ANALYSIS; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; HYDROXYUREA; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 4444346176     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh308     Document Type: Article

References (35)

1. American Cancer Society. Cancer Facts and Figures 2003. American Cancer Society Website. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf Accessed. December 23, 2003.
2. The Department of Veterans Affairs Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-1690.
3. Lefebvre JL, Chevalier D, Luboinski B et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase II trial. J Natl Cancer Inst 1996; 88: 890-899.
4. Forastiere AA, Goepfert H, Maor M et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
5. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001; 345: 1890-1900.
6. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual patient data. Lancet 2000; 355: 949-955.
7. Koness RJ, Glicksman A, Liu L et al. Recurrence patterns with concurrent platinum based chemotherapy and accelerated hyperfractionated radiotherapy in stage III and IV head and neck cancer. Am J Surg 1997; 174: 532-535.
8. Garden AS, Pajek TF, Vokes E et al. Preliminary results of RTOG 9703 - a phase II randomized trial of concurrent radiation (RT) and chemotherapy for advanced squamous cell carcinoma of the head and neck. Proc Am Soc Clin Oncol 2001; 20: 891 (Abstr).
9. Robbins KT, Kumar P, Regine WF et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis Experience. Int J Radiation Oncol Biol Phys 1997; 38: 263-271.
10. Vokes EE, Kies M, Haraf DJ et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 2000; 18: 1652-1661.
11. Kies MS, Haraf DJ, Rosen F et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 2001; 19: 1961-1969.
12. Adelstein DJ, Saxton JP, Lavertu P et al. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol 2002; 20: 1405-1410.
13. Vokes EE, Panje WR, Schilsky R et al. Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer. J Clin Oncol 1989; 7: 761-768.
14. Byfield JE, Sharp TR, Frankel SS et al. Phase I and II trial of five-day infused 5-fluorouracil and radiation in advanced cancer of the head and neck. J Clin Oncol 1984; 2: 406-413.
15. Taylor SGIV, Murthy AK, Caldarelli DD et al. Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol 1989; 7: 846-856.
16. Vokes EE, Kies MS, Haraf DJ et al. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol 1995; 13: 876-883.
17. Kies MS, Haraf DJ, Athanasiadis I et al. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol 1998; 16: 2715-2721.
18. Rosen FR, Haraf DJ, Kies MS et al. Multicenter randomized phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer. Clin Cancer Res 2003; 9: 1689-1697.
19. Glicksman AS, Wanebo HJ, Slotman G et al. Concurrent platinum based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1997; 39: 721-729.
20. Leyvraz S, Pasche P, Bauer J et al. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma; four year results of a phase I/II study. J Clin Oncol 1994; 12: 1876-1885.
21. Adelstein DJ, Lavertu P, Saxton JP et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000; 88: 876-883.
22. Clark JR, Busse PM, Norris CM Jr et al. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results. J Clin Oncol 1997; 15: 3100-3110.
23. Cerezo L, Millan I, Torre A et al. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer 1992; 69: 1224-1234.
24. Mamelle G, Pampurik J, Luboinski B et al. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 1994; 68: 494-498.
25. Fortin A, Couture C, Doucet R et al. Does histologic grade have a role in the management of head and neck cancers? J Clin Oncol 2001; 19: 4107-4116.
26. Taylor SG, Murthy AK, Vannetzel P et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994; 12: 385-395.
27. Leemans CR, Tiwari R, Nauta JJ et al. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993; 71: 452-456.
28. Vikram B, Strong EW, Shah JP, Spiro R. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984; 6: 730-733.
29. Laramore GB, Scott CB, Al-Sarraf M et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup study 0034. Int J Radiat Oncol Biol Phys 1992; 23: 705-713.
30. Paccagnella A, Orlando A, Marchiori C et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio Sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994; 86: 265-272.
31. Head and Neck Contracts Program. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the head and neck contracts program. Cancer 1987; 60: 301-311.
32. Schuller DE, Metch B, Stein DW et al. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope 1988; 98: 1205-1211.
33. Domenge C, Hill C, Lefebvre JL et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br J Cancer 2000; 83: 1594-1598.
34. Vokes EE, Stenson K, Rosen F et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 2003; 21: 320-326.
35. Haraf DJ, Rosen FR, Stenson K et al. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res 2003; 9: 5936-5943.